{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T17:44:53Z","timestamp":1775497493377,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.vaccine.2008.07.105","type":"journal-article","created":{"date-parts":[[2008,9,7]],"date-time":"2008-09-07T14:16:00Z","timestamp":1220796960000},"page":"5883-5887","source":"Crossref","is-referenced-by-count":32,"title":["Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands"],"prefix":"10.1016","volume":"26","author":[{"given":"Silke","family":"David","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia E.","family":"Vermeer-de Bondt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoline A.T.","family":"van der Maas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.07.105_bib1","unstructured":"Gezondheidsraad. Vaccinatie tegen Kinkhoest. 2004; publicatienr 2004\/04:1\u2013117."},{"key":"10.1016\/j.vaccine.2008.07.105_bib2","unstructured":"Vaccinatie van zuigelingen tegen pneumokokkeninfecties. Gezondheidsraad 2005."},{"key":"10.1016\/j.vaccine.2008.07.105_bib3","unstructured":"Vermeer-de Bondt PE, Dzaferagic A, Phaff TAJ, Wesselo C, Maas van der NAT. Adverse Events Following Immunisation under the National Vaccination Programme of The Netherlands, number 11. Reports in 2004. Bilthoven, The Netherlands: National Institute for public Health and the Environment, 2005; 240071002. http:\/\/www.rivm.nl\/bibliotheek\/rapporten\/240071002.html."},{"key":"10.1016\/j.vaccine.2008.07.105_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine","volume":"334","author":"Gustafsson","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2008.07.105_bib5","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)06508-2","article-title":"Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine Ad Hoc Group for the Study of Pertussis Vaccines","volume":"350","author":"Olin","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.07.105_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM199602083340601","article-title":"A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis Progetto Pertosse Working Group","volume":"334","author":"Greco","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2008.07.105_bib7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0264-410X(97)00163-1","article-title":"Predictors of adverse events after the administration of acellular and whole-cell diphtheria-tetanus-pertussis vaccines","volume":"16","author":"Tozzi","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.105_bib8","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1016\/S0264-410X(03)00404-3","article-title":"Adverse event reporting rates following tetanus-diphtheria and tetanus toxoid vaccinations: data from the Vaccine Adverse Event Reporting System (VAERS), 1991\u20131997","volume":"21","author":"Lloyd","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.105_bib9","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0264-410X(02)00770-3","article-title":"Systematic review of the effects of pertussis vaccines in children","volume":"21","author":"Jefferson","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.105_bib10","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1016\/j.vaccine.2006.04.019","article-title":"Assessment of nine candidate DTP-vaccines with reduced amount of antigen and\/or without adjuvant as a fourth (booster-) dose in the second year of life","volume":"24","author":"Knuf","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.105_bib11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0264-410X(03)00511-5","article-title":"Standardized case definitions of adverse events following immunization (AEFI)","volume":"22","author":"Bonhoeffer","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.105_bib12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.vaccine.2003.09.009","article-title":"Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation","volume":"22","author":"Bonhoeffer","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.105_bib13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.vaccine.2003.09.006","article-title":"Persistent crying in infants and children as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation","volume":"22","author":"Bonhoeffer","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.105_bib14","doi-asserted-by":"crossref","first-page":"7066","DOI":"10.1016\/j.vaccine.2006.07.008","article-title":"Performance of the Brighton collaboration case definition for hypotonic-hyporesponsive episode (HHE) on reported collapse reactions following infant vaccinations in the Netherlands","volume":"24","author":"Vermeer-de Bondt","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.105_bib15","first-page":"22","article-title":"Toename van bijwerkingen van vaccinaties in 2004","volume":"39","author":"Veen van der","year":"2007","journal-title":"Tijdschr Voor Jeugdgezondheidszorg"},{"key":"10.1016\/j.vaccine.2008.07.105_bib16","unstructured":"Maas van der NAT, David S, Kemmeren JM, Vermeer-de Bondt PE. Veiligheidsbewaking van het Rijksvaccinatieprogramma; minder bijwerkingen van DKTP-Hib-combinatievaccin sinds de overgang in 2005 naar vaccin met acellulaire kinkhoestcomponent NTVG; 2007; 151:2732\u201337."},{"key":"10.1016\/j.vaccine.2008.07.105_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.inf.0000148923.46453.48","article-title":"Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine","volume":"24","author":"Tichmann-Schumann","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.07.105_bib18","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1016\/S0264-410X(03)00389-X","article-title":"The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine","volume":"21","author":"Schmitt","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.07.105_bib19","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jpeds.2006.06.016","article-title":"Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine","volume":"149","author":"Zepp","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2008.07.105_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jpeds.2007.02.013","article-title":"Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine","volume":"151","author":"Pichichero","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2008.07.105_bib21","unstructured":"Maas van der NAT, Wesselo C, Phaff TAJ, Vermeer-de Bondt PE. Adverse Events Following Immunisation under the National Vaccination Programme of The Netherlands, number 13. Reports in 2006. Bilthoven, The Netherlands: National Institute for public Health and the Environment, 2007; 240071004. http:\/\/www.rivm.nl\/bibliotheek\/rapporten\/240071004.html."},{"key":"10.1016\/j.vaccine.2008.07.105_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/INF.0b013e318162a127","article-title":"The effect of age and dose number on the risk of collapse (hypotonic-hyporesponsive episode) after pertussis vaccination","volume":"27","author":"Vermeer-de Bondt","year":"2008","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08010414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08010414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T22:55:42Z","timestamp":1545778542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08010414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":22,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0264410X08010414"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.07.105","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}